Last year, Health and Human Services Secretary RFK Jr. called mRNA vaccines for respiratory viruses unsafe for the public and the National Institutes of Health cut 22 programs totaling $500 million that targeted mRNA vaccine research for infectious diseases. Now, that same technology has succeeded in a clinical trial for treating skin cancer. CNN’s Meg Tirrell reports.
MRNA vaccine for skin cancer succeeds in clinical trial
